Esophageal cancer remains one of the world’s deadliest cancers, ranking 7th in incidence and 6th in cancer-related deaths globally. In East Asia and Japan, over 90% of these cases are esophageal squamous cell carcinoma (ESCC). A reason for poor treatment outcomes is the high recurrence of ESCC, with only 55% to 63.6% of patients remaining cancer-free five years after treatment.
This article was originally published on MedicalXpress.com